Ad campaign for controversial Alzheimer’s drug will ‘overly medicalize’ normal age-related memory loss, some experts say 5 min read Latest Ad campaign for controversial Alzheimer’s drug will ‘overly medicalize’ normal age-related memory loss, some experts say international July 23, 2021 Facing a host of challenges, Aduhelm’s makers Biogen and its partner Eisai are taking a page right...Read More
international